pembrolizumab
merck
['congrat', 'kn412']
excellent trial and congrats all authors and patients, but unfortunately the result of kn412 is a negative trial, it doesn't exist trend #esmo2022 
Scientific Committee Member LACOG - GU. Medical Oncologist at Hospital Albert Einstein and CPO. Owner and founder BIO. Following or RT does not mean endorsement